Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis.
about
Comparison of early onset sepsis and community-acquired late onset sepsis in infants less than 3 months of age'Tweaking' the model for understanding and preventing maternal and neonatal morbidity and mortality in Low Income Countries: "inserting new ideas into a timeless wine skin".Use of a decision-analytic model in a health technology assessment: beyond measuring value for money.2010 perinatal GBS prevention guideline and resource utilization.The ongoing challenge to prevent neonatal sepsis.Methodology for computing the burden of disease of adverse events following immunization.
P2860
Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Should Israel screen all mothe ...... ease? A cost-utility analysis.
@ast
Should Israel screen all mothe ...... ease? A cost-utility analysis.
@en
type
label
Should Israel screen all mothe ...... ease? A cost-utility analysis.
@ast
Should Israel screen all mothe ...... ease? A cost-utility analysis.
@en
prefLabel
Should Israel screen all mothe ...... ease? A cost-utility analysis.
@ast
Should Israel screen all mothe ...... ease? A cost-utility analysis.
@en
P2093
P2860
P356
P1476
Should Israel screen all mothe ...... ease? A cost-utility analysis.
@en
P2093
Arthur I Eidelman
Emilia Anis
Eric Shinwell
Reuven Peyser
Yoram Lotan
P2860
P2888
P356
10.1186/2045-4015-2-6
P577
2013-02-20T00:00:00Z
P5875
P6179
1023859723